The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...

The Food and Drug Administration has outlined new regulations for COVID-19 booster shots, setting stricter approval standards ...

Top officials for the Food and Drug Administration (FDA) laid out new requirements for yearly updates to COVID-19 shots, ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...